Advanced or Recurrent Endometrial Cancer Clinical Trial
0 Views
administrator
07/09/23
The purpose of this clinical trial is to study the good and bad effects of adding the PD-1 inhibitor called pembrolizumab to standard treatment for advanced or recurrent endometrial cancer. http://www.bigtencrc.org
-
Category
Show more
Facebook Comments
No comments found